Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chimerix Inc
(NQ:
CMRX
)
1.380
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
501,443
Open
1.370
Bid (Size)
1.360 (6)
Ask (Size)
1.440 (17)
Prev. Close
1.380
Today's Range
1.325 - 1.395
52wk Range
1.090 - 2.898
Shares Outstanding
86,249,744
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
May 31, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
May 25, 2023
Forum Aim is to Share Progress and Spur Actions to Advance the Field
From
Chimerix, Inc.
Via
GlobeNewswire
Performance
YTD
-26.20%
-26.20%
1 Month
+15.97%
+15.97%
3 Month
-13.21%
-13.21%
6 Month
-36.41%
-36.41%
1 Year
-26.60%
-26.60%
More News
Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
May 23, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
May 22, 2023
Via
Benzinga
Chimerix Earnings Preview
May 03, 2023
Via
Benzinga
Looking Into Chimerix's Return On Capital Employed
March 08, 2023
Via
Benzinga
Chimerix's Earnings Outlook
March 01, 2023
Via
Benzinga
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
May 04, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
April 27, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
April 18, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
April 05, 2023
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
Via
Benzinga
Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?
March 10, 2023
Via
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 02, 2023
Via
Benzinga
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
March 02, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
February 28, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023
February 23, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Overlooked Value Stocks That Could Outperform the Market
February 13, 2023
Via
InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
February 07, 2023
Via
InvestorPlace
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Via
InvestorPlace
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
December 08, 2022
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Responds to Rubric Capital Management
November 10, 2022
From
Chimerix, Inc.
Via
GlobeNewswire
Rubric Capital Management Sends Letter to Chimerix Board of Directors
November 10, 2022
From
Rubric Capital Management LP
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.